Search Results 971-980 of 18586 for hepatitis

  1. Video Audio [voiceover] It started subtly — no sign anything was amiss, just some itching and rashes developing on both of Jay

    A trip to his primary care physician in 2012 led to an initial diagnosis of hepatitis, a prescription for antibiotics and a recommendation to call again if ...

  2. Surgery - Doctors - Mayo Clinic

    ... hepatitis, Autoimmune hepatitis, Hepatocellular carcinoma, Wilson's disease, Hepatopulmonary syndrome, Primary biliary cholangitis, Portopulmonary ...

  3. Tofacitinib (oral route) - Mayo Clinic

    May increase risk of developing infections. Heart or blood vessel disease or; Hepatitis B, history of or; Hepatitis C, history of or; Herpes zoster infection ...

  4. A Study to Evaluate Binimetinib in Combination with Encorafenib in Patients with Pancreatic Malignancies and a Somatic BRAFV600E Mutation - Mayo Clinic

    Evidence of hepatitis B Virus (HBV) or hepatitis C Virus (HCV) infection. NOTE: Patients with laboratory evidence of cleared HBV or HCV infection may ...

  5. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

    Patients must be tested for hepatitis B virus (HBV), hepatitis B surface antigen (HBsAg+) and hepatitis C (HCV) antibody within 6 weeks of registration.

  6. Hepatobiliary SPORE Quarterly Newsletter - Mayo Clinic

    campaign to promote hepatitis screening, follow-up care, and early cancer detection (prevention) educational programs that are culturally and linguistically ...

  7. Publications - M. Edwyn Harrison, M.D. - Mayo Clinic

    Micro-RNA-122 levels in acute liver failure and chronic hepatitis C. J Med Virol. 2014 Sep; 86: (9)1507-14. View PubMed; Salah W, Harrison ME, Faigel DO, ...

  8. Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (FRAPPE) - Mayo Clinic

    ... Hepatitis C virus (defined as anti-HCV Ab positive and detectable HCV RNA) ... - For patients with evidence of hepatitis B virus (HBV) infection (hepatitis ...

  9. Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305) - Mayo Clinic

    ... hepatitis C infection (participants with hepatitis C that achieve a sustained virologic response after antiviral therapy are allowed), or hepatitis B ...

  10. APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis - Mayo Clinic

    Have negative serology for hepatitis B virus (HBV) and hepatitis C virus (HCV). Exclusion Criteria: Had a prior liver transplant or is planned to undergo ...